NORML Sends Over 10000 Public Comments Supporting Cannabis Reform to the FDA

0
134

The Food and Drug Administration has been soliciting public commentary on whether to continue scheduling cannabis as a dangerous drug with no medical use. For the past month, the Food and Drug Administration has been soliciting public commentary on whether or not the classification of cannabis as a dangerous drug with no medical use should remain in effect. This week, cannabis advocacy group NORML hand-delivered over 10,000 written comments to the FDA, all urging both federal and international agencies to reconsider the longstanding prohibition of marijuana. Under both U.S. and international law, cannabis is lumped in with crack, heroin, and a number of other drugs that are considered highly dangerous, addictive, and devoid of any medical use. Several international treaties technically prohibit U.N. member countries from legalizing the plant, although Canada is planning to implement adult-use cannabis legalization nationwide in spite of these treaties. NORML Sends Over 10000 Public Comments Supporting Cannabis Reform to the FDA

thumbnail courtesy of merryjane.com

LEAVE A REPLY

Please enter your comment!
Please enter your name here